Literature DB >> 10392708

Hemangioblast development and regulation.

K Choi1.   

Abstract

Hematopoietic and endothelial cell lineages are the first to mature from mesoderm in the developing embryo. However, little is known about the molecular and (or) cellular events leading to hematopoietic commitment. The recent applications of technology utilizing gene targeted mice and the employment of many available in vitro systems have facilitated our understanding of hematopoietic establishment in the developing embryo. It is becoming clear that embryonic hematopoiesis occurs both in the extra-embryonic yolk sac and within the embryo proper in the mouse. The existence of the long pursued hemangioblast, a common progenitor of hematopoietic and endothelial cells, is now formally demonstrated. Based on this new information, many studies are being conducted to understand hematopoietic commitment events from mesoderm. In this review, we will first discuss the establishment of the hematopoietic system with special emphasis on the most primitive hematopoietic committed cells, the hemangioblast. We will then discuss mesoderm-inducing factors and their possible role in hematopoietic lineage commitment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10392708

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  16 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Multipotent adult progenitor cell and stem cell plasticity.

Authors:  Balkrishna N Jahagirdar; Catherine M Verfaillie
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4.

Authors:  Kimi Y Kong; Elizabeth A Williamson; Jason H Rogers; Tam Tran; Robert Hromas; Richard Dahl
Journal:  Blood       Date:  2009-03-25       Impact factor: 22.113

4.  From blood islands to blood vessels: morphologic observations and expression of key molecules during hyaloid vascular system development.

Authors:  D Scott McLeod; Takuya Hasegawa; Takayuki Baba; Rhonda Grebe; Ines Galtier d'Auriac; Carol Merges; Malia Edwards; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-03       Impact factor: 4.799

5.  Origin of endothelial progenitors in human postnatal bone marrow.

Authors:  Morayma Reyes; Arkadiusz Dudek; Balkrishna Jahagirdar; Lisa Koodie; Paul H Marker; Catherine M Verfaillie
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 6.  Hematopoietic stem/progenitor cell commitment to the megakaryocyte lineage.

Authors:  Carolien M Woolthuis; Christopher Y Park
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

7.  Effect of Calcium-Infiltrated Hydroxyapatite Scaffolds on the Hematopoietic Fate of Human Umbilical Vein Endothelial Cells.

Authors:  Qinghao Zhang; Jörg C Gerlach; Eva Schmelzer; Ian Nettleship
Journal:  J Vasc Res       Date:  2017-11-23       Impact factor: 1.934

8.  The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells.

Authors:  Hao Bai; Yin-Liang Xie; Yong-Xing Gao; Tao Cheng; Zack Z Wang
Journal:  Stem Cells Dev       Date:  2013-07-19       Impact factor: 3.272

9.  phlda3 overexpression impairs specification of hemangioblasts and vascular development.

Authors:  Xiaojing Wang; Jia Li; Zhongcheng Yang; Li Wang; Lei Li; Wenqing Deng; Juan Zhou; Longfei Wang; Chengqi Xu; Qiuyun Chen; Qing K Wang
Journal:  FEBS J       Date:  2018-09-20       Impact factor: 5.542

10.  Human embryonic stem cells hemangioblast express HLA-antigens.

Authors:  Grzegorz Wladyslaw Basak; Satoshi Yasukawa; Andre Alfaro; Samantha Halligan; Anand S Srivastava; Wei-Ping Min; Boris Minev; Ewa Carrier
Journal:  J Transl Med       Date:  2009-04-22       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.